Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Panel To Weigh Safety, Tolerability Issues For One New, Two Approved Cancer Drugs
Jul 21 2022
•
By
Sue Sutter
FDA has issued safety alerts about Pepaxto and Copiktra, two of the three drugs ODAC will discuss at a September meeting. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers